MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
(note 5)
$548,880K
Cash and cash
equivalents
$545,867K
Prepaid expenses and
other current assets
$10,720K
Other receivables
$1,165K
Total current assets
$1,106,632K
Marketable securities,
long-term (note 4)
$244,874K
Deferred tax assets
$12,417K
Prepaid expenses,
long-term
$8,305K
Property, plant and
equipment, net
$8,294K
Operating lease
right-of-use asset, net (note...
$6,288K
Total assets
$1,386,810K
Total liabilities and
shareholders equity
$1,386,810K
Total shareholders'
equity
$1,337,819K
Total liabilities
$48,991K
Accumulated deficit
-$1,347,682K
Accumulated other
comprehensive income (loss)
-$1,211K
Common shares, without
par value unlimited...
$2,421,833K
Total current
liabilities
$39,815K
Operating lease
liability, long-term (note...
$5,930K
Other liabilities,
long-term
$3,246K
Additional paid-in capital
$264,879K
Accounts payable and
accrued liabilities...
$38,254K
Operating lease liability
(note 5)
$1,561K
Back
Back
Balance Sheet
logo_icon_teal_2280px-svg
Xenon Pharmaceuticals Inc. (XENE)
logo_icon_teal_2280px-svg
source: myfinsight.com
Xenon Pharmaceuticals Inc. (XENE)